Links to 4 Hepatitis C Articles

July 13, 2011

Amarillo Biosciences Releases Corporate Progress Report

MarketWatch (press release)

Subjects were given low-dose oral interferon or placebo for 24 weeks to judge

the effect on the relapse rate in hepatitis C patients who achieved virologic

remission after treatment with Ribavirin and high-dose injectable interferon.

....

See all stories on this topic »AM Vitals: Pharma Pipelines Filling Up

Wall Street Journal (blog)

New drugs to treat melanoma, lupus and hepatitis C are among the 20 approved so

far this year, compared to 21 for all of 2010. Analysts say new, innovative

drugs have the potential to cushion the blow from the major patent expirations

set to dent the ...

See all stories on this topic »Human cell types important for Hepatitis C Virus

replication in vivo and in ...

7thSpace Interactive (press release)

Hepatitis C Virus (HCV) is a single stranded RNA virus which produces negative

strand RNA as a replicative intermediate. We analyzed 75 RT-PCR studies that

tested for negative strand HCV RNA in liver and other human tissues. ...

See all stories on this topic »Drug companies' research rebounding

UPI.com

After years of research misses, recently approved innovations include the first

therapy shown to extend life for people with advanced melanoma, the first new

treatment for lupus in more 50 years and two more effective drugs for hepatitis

C, ...

See all stories on this topic »

July 13, 2011